Medisanté Earns Acclaim from Frost & Sullivan for Ensuring Better Care Outcomes while Reducing Costs
With its global medical IoT infrastructure, Medisanté radically simplifies PGHD integration into clinical systems and enables healthcare providers to scale their RPM initiatives
Based on its recent analysis of the global remote patient monitoring (RPM) market, Frost & Sullivan recognizes Medisanté with the 2019 Global Enabling Technology Leadership Award for integrating patient-generated health data (PGHD) direct-to-cloud into any existing clinical system. Medisanté’s powerful partnership strategy is key to its success in streamlining RPM initiatives anywhere in the world. By combining advanced technology from Vodafone (for cellular IoT technology), Amazon Web Services (for cloud infrastructure), and Gemalto (for chip cards and enterprise-grade security), Medisanté makes RPM more accessible to care teams and patients. It also involves biomedical engineers to facilitate secure and cost-effective scaling.
"Medisanté simplifies connectivity at the endpoint in the patient’s home in order to globally scale RPM using cloud technologies," said Victor Camlek, Research Manager at Frost & Sullivan. "It achieves this by embedding a global roaming IoT SIM card from Vodafone into medical devices, eliminating the need to pair them with a physical mobile gateway such as a tablet or a mobile phone. With no effort by the patient, devices transmit readings directly from the home to the care team."